Through a series of experiments described above, we demonstrated that KDM5B could target miR‐448 at the cellular level, and miR‐448 inhibited HCC by targeting the YTHDF3/ITGA6 axis. This evidence concerns the gene ITGA6 and hepatocellular carcinoma.